141 related articles for article (PubMed ID: 35838046)
1. KRAS mutations as essential promoters of lymphangiogenesis via extracellular vesicles in pancreatic cancer.
Pirlog R; Calin GA
J Clin Invest; 2022 Jul; 132(14):. PubMed ID: 35838046
[TBL] [Abstract][Full Text] [Related]
2. KRAS mutant-driven SUMOylation controls extracellular vesicle transmission to trigger lymphangiogenesis in pancreatic cancer.
Luo Y; Li Z; Kong Y; He W; Zheng H; An M; Lin Y; Zhang D; Yang J; Zhao Y; Chen C; Chen R
J Clin Invest; 2022 Jul; 132(14):. PubMed ID: 35579947
[TBL] [Abstract][Full Text] [Related]
3. Mutant KRAS Mediates circARFGEF2 Biogenesis to Promote Lymphatic Metastasis of Pancreatic Ductal Adenocarcinoma.
Kong Y; Luo Y; Zheng S; Yang J; Zhang D; Zhao Y; Zheng H; An M; Lin Y; Ai L; Diao X; Lin Q; Chen C; Chen R
Cancer Res; 2023 Sep; 83(18):3077-3094. PubMed ID: 37363990
[TBL] [Abstract][Full Text] [Related]
4. Combined targeting of TGF-β, EGFR and HER2 suppresses lymphangiogenesis and metastasis in a pancreatic cancer model.
Gore J; Imasuen-Williams IE; Conteh AM; Craven KE; Cheng M; Korc M
Cancer Lett; 2016 Aug; 379(1):143-53. PubMed ID: 27267807
[TBL] [Abstract][Full Text] [Related]
5. SUMOylation-triggered ALIX activation modulates extracellular vesicles circTLCD4-RWDD3 to promote lymphatic metastasis of non-small cell lung cancer.
Diao X; Guo C; Zheng H; Zhao K; Luo Y; An M; Lin Y; Chen J; Li Y; Li Y; Gao X; Zhang J; Zhou M; Bai W; Liu L; Wang G; Zhang L; He X; Zhang R; Li Z; Chen C; Li S
Signal Transduct Target Ther; 2023 Nov; 8(1):426. PubMed ID: 37925421
[TBL] [Abstract][Full Text] [Related]
6. Wild‑type KRAS inhibits the migration and invasion of pancreatic cancer through the Wnt/β‑catenin pathway.
Hu X; Zhang R; Yao J; Mu B; Zhao C
Mol Med Rep; 2023 Jan; 27(1):. PubMed ID: 36367161
[TBL] [Abstract][Full Text] [Related]
7. Loss of Somatostatin Receptor Subtype 2 Promotes Growth of KRAS-Induced Pancreatic Tumors in Mice by Activating PI3K Signaling and Overexpression of CXCL16.
Chalabi-Dchar M; Cassant-Sourdy S; Duluc C; Fanjul M; Lulka H; Samain R; Roche C; Breibach F; Delisle MB; Poupot M; Dufresne M; Shimaoka T; Yonehara S; Mathonnet M; Pyronnet S; Bousquet C
Gastroenterology; 2015 Jun; 148(7):1452-65. PubMed ID: 25683115
[TBL] [Abstract][Full Text] [Related]
8. SUMOylation promotes extracellular vesicle-mediated transmission of lncRNA ELNAT1 and lymph node metastasis in bladder cancer.
Chen C; Zheng H; Luo Y; Kong Y; An M; Li Y; He W; Gao B; Zhao Y; Huang H; Huang J; Lin T
J Clin Invest; 2021 Apr; 131(8):. PubMed ID: 33661764
[TBL] [Abstract][Full Text] [Related]
9. circNFIB1 inhibits lymphangiogenesis and lymphatic metastasis via the miR-486-5p/PIK3R1/VEGF-C axis in pancreatic cancer.
Kong Y; Li Y; Luo Y; Zhu J; Zheng H; Gao B; Guo X; Li Z; Chen R; Chen C
Mol Cancer; 2020 May; 19(1):82. PubMed ID: 32366257
[TBL] [Abstract][Full Text] [Related]
10. GNAS
Ideno N; Yamaguchi H; Ghosh B; Gupta S; Okumura T; Steffen DJ; Fisher CG; Wood LD; Singhi AD; Nakamura M; Gutkind JS; Maitra A
Gastroenterology; 2018 Nov; 155(5):1593-1607.e12. PubMed ID: 30142336
[TBL] [Abstract][Full Text] [Related]
11. Disruption of p16 and activation of Kras in pancreas increase ductal adenocarcinoma formation and metastasis in vivo.
Qiu W; Sahin F; Iacobuzio-Donahue CA; Garcia-Carracedo D; Wang WM; Kuo CY; Chen D; Arking DE; Lowy AM; Hruban RH; Remotti HE; Su GH
Oncotarget; 2011 Nov; 2(11):862-73. PubMed ID: 22113502
[TBL] [Abstract][Full Text] [Related]
12. Regulation of oncogenic KRAS signaling via a novel KRAS-integrin-linked kinase-hnRNPA1 regulatory loop in human pancreatic cancer cells.
Chu PC; Yang MC; Kulp SK; Salunke SB; Himmel LE; Fang CS; Jadhav AM; Shan YS; Lee CT; Lai MD; Shirley LA; Bekaii-Saab T; Chen CS
Oncogene; 2016 Jul; 35(30):3897-908. PubMed ID: 26616862
[TBL] [Abstract][Full Text] [Related]
13. Loss of Pten and Activation of Kras Synergistically Induce Formation of Intraductal Papillary Mucinous Neoplasia From Pancreatic Ductal Cells in Mice.
Kopp JL; Dubois CL; Schaeffer DF; Samani A; Taghizadeh F; Cowan RW; Rhim AD; Stiles BL; Valasek M; Sander M
Gastroenterology; 2018 Apr; 154(5):1509-1523.e5. PubMed ID: 29273451
[TBL] [Abstract][Full Text] [Related]
14. Role of lymphangiogenesis and lymphangiogenic factors during pancreatic cancer progression and lymphatic spread.
Schneider M; Büchler P; Giese N; Giese T; Wilting J; Büchler MW; Friess H
Int J Oncol; 2006 Apr; 28(4):883-90. PubMed ID: 16525637
[TBL] [Abstract][Full Text] [Related]
15. Extrinsic KRAS Signaling Shapes the Pancreatic Microenvironment Through Fibroblast Reprogramming.
Velez-Delgado A; Donahue KL; Brown KL; Du W; Irizarry-Negron V; Menjivar RE; Lasse Opsahl EL; Steele NG; The S; Lazarus J; Sirihorachai VR; Yan W; Kemp SB; Kerk SA; Bollampally M; Yang S; Scales MK; Avritt FR; Lima F; Lyssiotis CA; Rao A; Crawford HC; Bednar F; Frankel TL; Allen BL; Zhang Y; Pasca di Magliano M
Cell Mol Gastroenterol Hepatol; 2022; 13(6):1673-1699. PubMed ID: 35245687
[TBL] [Abstract][Full Text] [Related]
16. Heterogeneity of KRAS Mutations in Pancreatic Ductal Adenocarcinoma.
Hashimoto D; Arima K; Yokoyama N; Chikamoto A; Taki K; Inoue R; Kaida T; Higashi T; Nitta H; Ohmuraya M; Hirota M; Beppu T; Baba H
Pancreas; 2016 Sep; 45(8):1111-4. PubMed ID: 26967456
[TBL] [Abstract][Full Text] [Related]
17. Laminin γ2-enriched extracellular vesicles of oral squamous cell carcinoma cells enhance in vitro lymphangiogenesis via integrin α3-dependent uptake by lymphatic endothelial cells.
Wang SH; Liou GG; Liu SH; Chang JS; Hsiao JR; Yen YC; Chen YL; Wu WL; Chang JY; Chen YW
Int J Cancer; 2019 Jun; 144(11):2795-2810. PubMed ID: 30485433
[TBL] [Abstract][Full Text] [Related]
18. A genetically engineered mouse model developing rapid progressive pancreatic ductal adenocarcinoma.
Yamaguchi T; Ikehara S; Nakanishi H; Ikehara Y
J Pathol; 2014 Oct; 234(2):228-38. PubMed ID: 25042889
[TBL] [Abstract][Full Text] [Related]
19. Regulation of pH by Carbonic Anhydrase 9 Mediates Survival of Pancreatic Cancer Cells With Activated KRAS in Response to Hypoxia.
McDonald PC; Chafe SC; Brown WS; Saberi S; Swayampakula M; Venkateswaran G; Nemirovsky O; Gillespie JA; Karasinska JM; Kalloger SE; Supuran CT; Schaeffer DF; Bashashati A; Shah SP; Topham JT; Yapp DT; Li J; Renouf DJ; Stanger BZ; Dedhar S
Gastroenterology; 2019 Sep; 157(3):823-837. PubMed ID: 31078621
[TBL] [Abstract][Full Text] [Related]
20. Bmi1 combines with oncogenic KRAS to induce malignant transformation of human pancreatic duct cells in vitro.
Chen SJ; Chen YT; Zeng LJ; Zhang QB; Lian GD; Li JJ; Yang KG; Huang CM; Li YQ; Chu ZH; Huang KH
Tumour Biol; 2016 Aug; 37(8):11299-309. PubMed ID: 26951514
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
